Bioray Biotech Statistics

Total Valuation

Bioray Biotech has a market cap or net worth of TWD 676.02 million. The enterprise value is 583.59 million.

Market Cap	676.02M
Enterprise Value	583.59M

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Bioray Biotech has 29.59 million shares outstanding. The number of shares has decreased by -0.83% in one year.

Current Share Class	29.59M
Shares Outstanding	29.59M
Shares Change (YoY)	-0.83%
Shares Change (QoQ)	-1.55%
Owned by Insiders (%)	9.87%
Owned by Institutions (%)	n/a
Float	14.35M

Valuation Ratios

The trailing PE ratio is 674.67.

PE Ratio	674.67
Forward PE	n/a
PS Ratio	3.35
PB Ratio	1.61
P/TBV Ratio	1.61
P/FCF Ratio	50.34
P/OCF Ratio	40.59
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 28.96, with an EV/FCF ratio of 43.45.

EV / Earnings	582.43
EV / Sales	2.89
EV / EBITDA	28.96
EV / EBIT	n/a
EV / FCF	43.45

Financial Position

The company has a current ratio of 6.98, with a Debt / Equity ratio of 0.20.

Current Ratio	6.98
Quick Ratio	5.33
Debt / Equity	0.20
Debt / EBITDA	4.26
Debt / FCF	6.39
Interest Coverage	-3.26

Financial Efficiency

Return on equity (ROE) is 0.23% and return on invested capital (ROIC) is -0.53%.

Return on Equity (ROE)	0.23%
Return on Assets (ROA)	-0.50%
Return on Invested Capital (ROIC)	-0.53%
Return on Capital Employed (ROCE)	-0.86%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.37
Inventory Turnover	2.40

Taxes

In the past 12 months, Bioray Biotech has paid 378,000 in taxes.

Income Tax	378,000
Effective Tax Rate	27.39%

Stock Price Statistics

The stock price has decreased by -24.59% in the last 52 weeks. The beta is 0.32, so Bioray Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-24.59%
50-Day Moving Average	21.62
200-Day Moving Average	22.01
Relative Strength Index (RSI)	58.07
Average Volume (20 Days)	2,829

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioray Biotech had revenue of TWD 201.71 million and earned 1.00 million in profits. Earnings per share was 0.03.

Revenue	201.71M
Gross Profit	79.03M
Operating Income	-4.32M
Pretax Income	1.38M
Net Income	1.00M
EBITDA	12.05M
EBIT	-4.32M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 178.21 million in cash and 85.78 million in debt, giving a net cash position of 92.43 million or 3.12 per share.

Cash & Cash Equivalents	178.21M
Total Debt	85.78M
Net Cash	92.43M
Net Cash Per Share	3.12
Equity (Book Value)	420.73M
Book Value Per Share	14.22
Working Capital	261.66M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.65 million and capital expenditures -3.22 million, giving a free cash flow of 13.43 million.

Operating Cash Flow	16.65M
Capital Expenditures	-3.22M
Free Cash Flow	13.43M
FCF Per Share	0.45

Full Cash Flow Statement

Margins

Gross margin is 39.18%, with operating and profit margins of -2.14% and 0.50%.

Gross Margin	39.18%
Operating Margin	-2.14%
Pretax Margin	0.68%
Profit Margin	0.50%
EBITDA Margin	5.98%
EBIT Margin	-2.14%
FCF Margin	6.66%

Dividends & Yields

Bioray Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.83%
Shareholder Yield	n/a
Earnings Yield	0.15%
FCF Yield	1.99%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bioray Biotech has an Altman Z-Score of 4.62 and a Piotroski F-Score of 5.

Altman Z-Score	4.62
Piotroski F-Score	5